MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Vagotomy and Parkinson’s disease risk: A Swedish register-based matched cohort study

    B. Liu, F. Fang, N.L. Pedersen, A. Tillander, J.F. Ludvigsson, A. Ekbom, P. Svenningsson, H. Chen, K. Wirdefeldt (Stockholm, Sweden)

  • Vagus nerve stimulation as a novel treatment strategy for Parkinson’s disease

    A. Farrand, R. Gregory, K. Helke, S. Hays, V. Hinson, H. Boger (Charleston, SC, USA)

  • Validation of a screening questionnaire for X-linked dystonia parkinsonism (XDP): The first phase of the population based prevalence study of XDP in Panay

    J.D.B. Diestro, P.M.D. Pasco, L.V. Lee (Manila, Philippines)

  • Validation of an electronic motor diary for patients with Parkinson’s disease

    A. Medina, D. Cerquetti, F. Nanni, M. Rossi, M. Merello (Buenos Aires, Argentina)

  • Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

  • Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease

    S.J. Kim, E.J. Chung (Busan, Korea)

  • Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP)

    P.D. Pasco, L.V. Lee, R.G. Jamora, C.E. Diesta, A.R. Ng, R.A. Teleg, C.L. Go, R.L. Rosales, H.H. Fernandez (Manila, Philippines)

  • Validation study of Parkinson anxiety scale, Czech version

    N. Zemanová, M. Baláz (Brno, Czech Republic)

  • Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

    C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

  • Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

    H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)

  • Valproate-associated parkinsonism – A critical review of the literature

    F. Brugger, K.P. Bhatia, F.M.C. Besag (St. Gallen, Switzerland)

  • Valproate-induced reversible parkinsonism – A case series

    R.M. Simões, N. Inácio, V.B. Silva, A. Arraiolos, P. Alegria, N. Canas, J. Vale (Loures, Portugal)

  • VANTAGE trial: Three year outcomes of a prospective, multi-center trial evaluating deep brain stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

    L. Timmerman, R. Jain, L. Chen, T. Brucke, F. Seijo, E. Suarez San Martin, C. Haegelen, M. Verin, V. Visser-Vandewalle, M.T. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)

  • Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results

    J.D. Hilliard, T. Morishita, M.S. Okun, K.D. Foote (Gainesville, FL, USA)

  • Vascular degeneration in Parkinson’s disease

    J. Guan, P. Yang, R.L.M. Faill, M. Dragunow, H.J. Waldvogel (Auckland, New Zealand)

  • Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results

    E. Bayram, M.C. Akbostanci (Ankara, Turkey)

  • Verbal fluency deficits in essential tremor patients: Underlying structural changes

    E.A. Pelzer, C. Nelles, D.J. Pedrosa, L. Burghaus, C. Eggers, C. Melzer, M. Tittgemeyer, L. Timmermann (Cologne, Germany)

  • Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial

    J.L. Purks, A. Zeymo, N.M. Shara, K.E. Anderson, I. Shoulson (Washington, DC, USA)

  • Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

    A. Shalash, D. Hassan (Cairo, Egypt)

  • Video assessment of writer’s cramp

    J.E. Park, B. Karp (Bethesda, MD, USA)

  • Video-based tremor analysis via Kinect® System in comparison to accelerometric and electromyographical tremor detection

    F. Heinrich, T. Schmitz-Hübsch, T. Ellermeyer, S. Mansow-Model, A. Lipp (Berlin, Germany)

  • Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

    J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

  • Virtual rehabilitation: A therapy for parkinsonism?

    B.S. Zeigelboim, G.J.B. Santos, M.I.R. Severiano, H.A.G. Teive, A.B.M. Lacerda, C.M. Porto (Curitiba, Brazil)

  • Virtual-reality balance training with Nintendo-Wii games improves dynamic balance in Parkinson’s disease patients

    G.H. Lee (Cheon-An, Korea)

  • Visual hallucination and pattern of brain degeneration in Parkinson’s disease

    W.W. Lee, E.J. Yoon, J.Y. Lee, S.W. Park, Y.K. Kim (Seoul, Korea)

  • Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED

    D.H. Ffytche, F. D'Antonio, R. Pinto, D. Collerton, J.P. Taylor, D.J. Burn, R. Barker, D. Aarsland, R. Howard (London, United Kingdom)

  • Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia

    Y.P. Chang, Y.H. Yang, C.L. Lai, L.M. Liou (Kaohsiung, Taiwan)

  • Visual vs. automated analysis of [123I]FP-CIT SPECT scans in patients with parkinsonism

    E. Mäkinen, J. Joutsa, J. Johansson, M. Mäki, M. Seppänen, V. Kaasinen (Turku, Finland)

  • Vitamin D in early Parkinson’s disease

    I.M. Sleeman, T. Aspray, S. Coleman, G. Duncan, T.K. Khoo, I. Schoenmakers, L. Rochester, D.J. Burn, A.J. Yarnall (Newcastle, United Kingdom)

  • Vitamin D receptor polymorphisms and Parkinson’s disease in a Korean population: Revisited

    W. Jang, J.S. Kim (Gangneung, Korea)

  • Vocal fold augmentation in patients with Parkinson’s disease: A case series and review of the literature

    A.A. Thekdi (Houston, TX, USA)

  • Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease

    M.P. Cannito, L.O. Ramig, A.E. Halpern, J.L. Spielman (Lafayette, LA, USA)

  • Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

    L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

  • Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms

    M. Menendez Gonzalez, E. Suárez-Sanmartin, C. García, M. Blázquez Estrada (Mieres, Spain)

  • VOP/ZI deep brain stimulation for the relief of tremor in multiple sclerosis

    V. Levi, G. Messina, R. Cordella, I. Dones, A. Franzini (Milano, Italy)

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley